Evidence map›Paper›PMID 35117805›Full record

ArticleTranslational cancer research2020

Nomograms combined with

Xing-Chuan Li, Song Wang, Jia-Rui Zhu, Yu-Ping Wang, Yong-Ning Zhou

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. World journal of gastrointestinal oncology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xing-Chuan LiDepartment of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
Song WangDepartment of Radiotherapy, The First Hospital of Lanzhou University, Lanzhou, China.
Jia-Rui ZhuCuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou, China.
Yu-Ping WangDepartment of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
Yong-Ning ZhouDepartment of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerpin peptidase inhibitor, clade E, member 1 (

methodsA meta-analysis was performed to investigate

resultsMeta-analyses revealed an elevated trend in

conclusions

Indexed as

Computational biologymeta-analysisnomogramsplasminogen activator inhibitor-1 (PAI-1)stomach neoplasms

Identifiers

PMID35117805
PMCPMC8798744
OpenAlexW3044580045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.